Giacomo Barchiesi
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Sustained clinical benefit with sacituzumab govitecan in metastatic triple-negative breast cancer with extensive cutaneous involvement.
Journal: Recenti progressi in medicina
Published: July 16, 2026
Antibody-drug conjugates: a practical review on clinical management of toxicities.
Journal: Expert review of anticancer therapy
Published: June 03, 2026
Clinical relevance and prognostic role of PDL-1 expression in cervical cancer patients.
Journal: Archives of gynecology and obstetrics
Published: May 09, 2026
Outcomes of node-positive cervical cancer treated with neoadjuvant chemotherapy followed by radical surgery: a single-center approach to a challenging disease.
Journal: Journal of gynecologic oncology
Published: May 26, 2025
Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study.
Journal: Clinical breast cancer
Published: February 27, 2025
Warming-up the immune cell engagers (ICEs) era in breast cancer: state of the art and future directions.
Journal: Critical reviews in oncology/hematology
Published: July 22, 2024
Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments.
Journal: Critical reviews in oncology/hematology
Published: March 05, 2024
Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Journal: Cancers
Published: January 06, 2024
High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: a case report.
Journal: Frontiers in oncology
Published: October 04, 2023
Principles of belief acquisition. How we read other minds.
Journal: Consciousness and cognition
Published: June 14, 2023
Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab.
Journal: Critical reviews in oncology/hematology
Published: March 03, 2023
Last Updated: 09/26/2026